Cyclic Nucleotide-Mediated Regulation of Vascular Smooth Muscle Cell Cyclic Nucleotide Phosphodiesterase Activity: Selective Effect of Cyclic AMP

Cell Biochemistry and Biophysics

Volumn 29, Issue 1-2, 1998, Pages 35-47

  Maurice, D H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; 8-BROMOCYCLIC GMP; CYCLIC AMP; CYCLIC GMP; DRUG DERIVATIVE; EXONUCLEASE; FORSKOLIN; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; SPLEEN EXONUCLEASE;

ANIMAL; AORTA; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; RAT; VASCULAR SMOOTH MUSCLE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; 8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; AORTA; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; ENZYME ACTIVATION; EXONUCLEASES; FORSKOLIN; MUSCLE, SMOOTH, VASCULAR; NITROPRUSSIDE; PHOSPHORIC DIESTER HYDROLASES; RATS;

EID: 0031616364     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737827     Document Type: Article

References (19)

1. Beavo, J. A. and Reifsnyder, D. H. (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11, 150-155.
2. Bolger, G., Michaeli, T., Martins, T., St. John, T., Steiner, B., Rodgers, L., Riggs, M., Wigler, M., and Ferguson, K. (1993) A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol. Cell. Biol. 13, 6558-6571.
3. Manganiello, V. C., Taira, M., Degerman, E., and Belfrage, P. (1995) Type III cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE3 gene family). Cell Signaling 7, 445-455.
4. Lugnier, C., Schoeffter, P., Le Bec, A., Strouthou, E., and Stoclet, J. C. (1986) Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta. Biochem. Pharmacol. 35, 1743-1751.
5. Weishaar, R. E., Burrows, S. D., Kobylarz, D. C., Quade, M. M., and Evans, D. B. (1986) Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase and cardiotonic agents. Biochem. Pharmacol. 35, 787-800.
6. Schoeffter, P., Lugnier, C., Demesy-Waeldele, F., and Stoclet, J. C. (1987) Role of cAMP- and cGMP- phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study -with selective inhibitors. Biochem. Pharmacol. 36, 3965-3972.
7. Maurice, D. H., Crankshaw, D., and Haslam, R. J. (1991) Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle. Eur. J. Pharmacol. 192, 235-242.
8. Elks, M. L., Manganiello, V. C., and Vaughan, M. (1983) Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. J. Biol. Chem. 258, 8582-8587.
9. Swinnen, J. V., Joseph, D. R., and Conti, M. (1989) The mRNA encoding a high affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc. Natl. Acad. Sci. USA 86, 8197-8201.
10. Torphy, T. J., Zhou, H.-L., and Cieslinski, L. B. (1992) Stimulation of beta adrenoceptors in a human monocyte cell line (U937) upregulates cAMP-specific phosphodiesterase activity. J. Pharmacol. Exp. Ther. 263, 1195-1205.
11. Torphy, T. J., Zhou, H.-L., Foley, J. J., Sarau, H. M., Manning, C. D., and Barnette, M. S. (1995) Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin E2. J. Biol Chem. 270, 23,598-23,604.
12. Verghese, M. W., McConnell, R. T., Lenhard, J. M., Harnacher, L., and Jin, S.-L. C. (1995) Regulation of distinct cAMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol. Pharmacol. 47, 1164-1171.
13. Manning, C. D., McLaughlin, M. M., Livi, G. P., Cieslinski, L. B., Torphy, T. J., and Barnette, M. S. (1996) Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B. J. Pharmacol. Exp. Ther. 276, 810-818.
14. Pang, S. C. and Venance, S. L. (1992). Cultured smooth muscle approach in the study of hypertension. Can. J. Physiol. Pharmacol. 70, 573-579.
15. Davis, C. W. and Daly, J. W. (1979) A simple direct assay of 3′,5′-cyclic nucleotide phosphodiesterase activity based on the use of polyacrylamide-boronate affinity gel chromatography. J. Cyclic Nucleotide Res. 5, 65-74.
16. Dickinson, N. T., Jang, E. K., and Haslam, R. J. (1997) Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation. Biochem. J. 323, 371-377.
17. m cAMP phosphodiesterase markedly stimulates its catalytic activity. Proc. Natl. Acad. Sci. USA 85, 9071-9075.
18. Sette, C. and Conti, M. (1996) Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation. J. Biol. Chem. 271, 16,526-16,534.
19. Maurice, D. H., Senis, Y. A., Liu, H., Giles, A. R., and Horn, E. H. (1995) Cell layer-specific expression of cyclic nucleotide phosphodiesterases in rat arteries: Molecular cloning using isolated cell layers from paraformaldehyde-fixed tissues. J. Pharmacol. Toxicol. Methods 34, 175-185.